{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-015225","form_type":"8-K","ticker":"IRON","cik":"0001816736","company_name":"Disc Medicine, Inc.","filed_at":"2023-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.730737+00:00","generated_at":"2026-06-20T09:40:31.529852+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Disc Medicine enters into $100M at-the-market equity facility with SVB Securities","bullets":["Up to $100M of common stock may be sold through SVB Securities as sales agent.","Sales at market prices; company pays 3% commission on gross proceeds.","No minimum sales obligation; facility terminates upon full sale or termination.","Agreement includes standard representations, warranties, and indemnification."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-015225","json":"https://secwatch.observer/filing/0001193125-23-015225.json","markdown":"https://secwatch.observer/filing/0001193125-23-015225.md","text":"https://secwatch.observer/filing/0001193125-23-015225.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816736/000119312523015225/0001193125-23-015225-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816736/000119312523015225/d456405d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T09:40:31.529852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"da5a053bde9728782e1e81fd8c3c3e734b168974","claim":"Disc Medicine, Inc. entered into Sales Agreement with SVB Securities LLC valued at up to $100.0 million (effective 2023-01-25).","evidence_excerpt":"On January 25, 2023, Disc Medicine, Inc. (the “Company”) entered into a Sales Agreement (the “Agreement”) with SVB Securities LLC (“SVB Securities”) pursuant to which the Company may, from time to time in its sole discretion, issue and sell through SVB Securities, acting as sales agent, shares of the Company’s common stock, par value $0.0001 per share (the “Placement Shares”). The issuance and sale, if any, of Placement Shares with an aggregate offering price of up to $100.0 million by the Company under the Agreement will be made pursuant to a prospectus supplement to the Company’s registration statement on Form S-3 (File No. 333-269272), originally filed with the Securities and Exchange Commission (the “SEC”) on January 18, 2023, which became effective on January 24, 2023.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312523015225/0001193125-23-015225-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"SVB Securities LLC"},{"label":"Value","value":"up to $100.0 million"},{"label":"Effective","value":"2023-01-25"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}